PROLooking for more than just a company report? Upgrade to Pro now

DHG PHARMACEUTICAL JOINT-STOCK COMPANY

Active

Business ID 1800156801

84-292 / 3891 433 - 3890 095

DHG PHARMACEUTICAL JOINT-STOCK COMPANY

Active

Business ID 1800156801

84-292 / 3891 433 - 3890 095

DHG PHARMACEUTICAL JOINT-STOCK COMPANY

Active

Summary

Name:

DHG PHARMACEUTICAL JOINT-STOCK COMPANY

Business ID (TIN):

1800156801

Date of Registration:

15 Sep 2004

Registered Office:

Can Tho City Department of Planning and Investment

Ticker:

DHG

Address:

No. 288 Bis, Nguyen Van Cu Street, An Hoa Ward, Ninh Kieu District, Can Tho City, Vietnam

Phone:

84-292 / 3891 433 - 3890 095

Financial Statement:

2020, 2021, 2022, 2023, 2024

DHG PHARMACEUTICAL JOINT-STOCK COMPANY (CÔNG TY CỔ PHẦN DƯỢC HẬU GIANG) continues to lead Vietnam’s pharmaceutical industry as a benchmark for scale, profitability, and sustainable growth. Founded in 1974 and headquartered in Can Tho City, DHG has evolved into the largest and most consistently profitable domestic pharmaceutical company in Vietnam. It operates under business ID and tax code 1800156801 and is publicly listed on the Ho Chi Minh Stock Exchange (HOSE) under the ticker symbol DHG.

DHG PHARMACEUTICAL is legally structured as a public joint stock company, with a solid base of institutional and public shareholders. Among them, Taisho Pharmaceutical Co., Ltd. from Japan is the largest foreign strategic investor, holding a controlling stake. The company's executive leadership includes seasoned professionals in both Vietnamese and international pharmaceutical operations. Mr. Doan Duy Khuong currently serves as Chairman, with Ms. Pham Thi Viet Nga, the former long-time CEO, remaining an influential figure in strategic direction.

In 2023, DHG PHARMACEUTICAL posted total revenue of USD 200.68 million and an outstanding net profit of USD 32.00 million, achieving the highest profit margin among major Vietnamese pharmaceutical firms. The company reported total assets of USD 193.22 million and owner’s equity of USD 173.57 million, highlighting its conservative financial posture and excellent capital management. These indicators reflect DHG’s robust operational efficiency, high return on equity, and low dependence on external debt.

The company’s success is underpinned by its expansive GMP-WHO certified manufacturing facilities, a diversified product portfolio of over 300 items, and an integrated nationwide distribution network. DHG produces a wide range of medicines, including antibiotics, vitamins, OTC products, and traditional herbal remedies. It has also embraced international standards, entering partnerships to produce drugs under Japanese GMP protocols, giving it a strong competitive edge in both domestic and export markets.

With continued investment in R&D, digital transformation, and supply chain modernization, DHG PHARMACEUTICAL is not only a market leader in Vietnam but also an emerging player in regional pharmaceutical markets. It remains a model of corporate governance, product innovation, and financial discipline.

For institutional investors, healthcare buyers, and regulatory bodies, Vanguard Business Information LLC (VBI)provides in-depth company reports, risk assessments, and shareholder verification on DHG PHARMACEUTICAL and other leading firms. As of 2024, DHG’s strong performance places it at the forefront of Vietnam’s pharmaceutical future.

Legal Profile

English Name:

DHG PHARMACEUTICAL JOINT-STOCK COMPANY

Vietnamese Name:

CÔNG TY CỔ PHẦN DƯỢC HẬU GIANG

Short Name:

DHG PHARMA

Business ID (TIN):

1800156801

Date of Registration:

15 Sep 2004

Registered Office:

Can Tho City Department of Planning and Investment

Ticker:

DHG

Ownership Status:

FDI

Operation Status:

Active

Contacts

Key Decision Makers:

+ DANG T.T.H

+ TOSHIYUKI I

+ NGUYEN N.D

+ TOMOYUKI K

+ NGUYEN N.D

+ HO B.H

+ OSAMU F

Address:

No. 288 Bis, Nguyen Van Cu Street, An Hoa Ward, Ninh Kieu District, Can Tho City, Vietnam

Phone:

84-292 / 3891 433 - 3890 095

Representative office:

Unit 404-405, 4th Floor, The Landmark Building, No. 5B, Ton Duc Thang Street, Sai Gon Ward, Ho Chi Minh City, Vietnam

Branch:

No. 91B, Mang Nuoc Street, An Hai Ward, Hai Phong City, Vietnam

Branch:

No. 36-38, Trinh Dinh Thao Street, Cam Le Ward, Da Nang City, Vietnam

Branch:

No. 18-20-22, Road 33, Tran Lam Urban Area, Tran Lam Ward, Hung Yen Province, Vietnam

Branch:

No. 153A, Pham Van Dong Street, Vy Da Ward, Thua Thien Hue Province, Vietnam

Branch:

No. 06, Lane 146B, Nguyen Sy Sach Street, Truong Vinh Ward, Nghe An Province, Vietnam

Business Sector

Key business lines:

VSIC:

2100 Manufacture of pharmaceuticals, medicinal chemical and botanical products

NACE:

21.10 Manufacture of basic pharmaceutical products

Industry Sales Growth

CAGR (2019 - 2023)

-2.80%

YoY (2023)

-5.39%

Companies by industry

Company distribution and propportions

1,859

0.0639%

Key Industry Players

Top 10 companies in manufacture of pharmaceuticals, medicinal chemical and botanical products industry

dhg pharmaceutical joint-stock company vietnam pharmaceutical corporation traphaco joint stock company sanofi-aventis vietnam company limited imexpharm corporation hatay pharmaceutical joint stock company rohto-mentholatum (vietnam) co., ltd tenamyd pharmaceutical corporation sanofi vietnam shareholding company stellapharm j.v. co., ltd. – branch 1

Payment History

Purchase the report to access company details.

Financial Performance

Assets	-97.41%
Owner’s Equity	53.41%
Working Capital	42.89%
Net Worth	59.30%
Sales	35.24%
Operating income	37.53%
EBIT	22.72%
Gross Profit Margin	48.10%
Debt to EBITDA	-72.14%

📈 📊

Company Reports

Company Profile Report

Legal Profile

Contact and Location

Legal Representative

Shareholders

Business Operation

Assets

Owner's Equity

Sales

Profit

Company Standard Report

Legal Profile

Business Locations

Legal Representative

EBT

EBITDA

Working Capital

Tangible Net Worth

Financial Ratios

Balance Sheet

Profit and Loss Statement

Cash Flow Statement

Comprehensive Report

Report Summary

Legal Profile

Historical Information

Business Locations

Subsidiary and Affiliated Company

Management and Directors

Shareholders

Business Operation

Suppliers

Buyers

Credit Limit

Industry Information

Key Industry Players

Competitors

Negative Payment Records

Banking Information

Litigation Records; Negative News

Financial Ratios

Balance Sheet

Profit and Loss Statement

Cash Flow Statement

Opinion from Analysts

Specific Questions About DHG PHARMACEUTICAL JOINT-STOCK COMPANY

When did DHG PHARMACEUTICAL JOINT-STOCK COMPANY start operating?

DHG PHARMACEUTICAL JOINT-STOCK COMPANY was started in 15 Sep 2004

What industry does DHG PHARMACEUTICAL JOINT-STOCK COMPANY operate in?

DHG PHARMACEUTICAL JOINT-STOCK COMPANY is operating in "Manufacture of pharmaceuticals, medicinal chemical and botanical products" industry

How can I contact DHG PHARMACEUTICAL JOINT-STOCK COMPANY?

DHG PHARMACEUTICAL JOINT-STOCK COMPANY phone numbers is 84-292 / 3891 433 - 3890 095

What adverse news is there about DHG PHARMACEUTICAL JOINT-STOCK COMPANY?

DHG PHARMACEUTICAL JOINT-STOCK COMPANY’s has 2 bad news

What is stock symbol of DHG PHARMACEUTICAL JOINT-STOCK COMPANY?

DHG PHARMACEUTICAL JOINT-STOCK COMPANY’s stock symbol is DHG

Where is the location of DHG PHARMACEUTICAL JOINT-STOCK COMPANY?

DHG PHARMACEUTICAL JOINT-STOCK COMPANY is located at No. 288 Bis, Nguyen Van Cu Street, An Hoa Ward, Ninh Kieu District, Can Tho City, Vietnam

What is DHG PHARMACEUTICAL JOINT-STOCK COMPANY’s business registration?

DHG PHARMACEUTICAL JOINT-STOCK COMPANY business registration is 1800156801

My Order (0)

DHG PHARMACEUTICAL JOINT-STOCK COMPANY

DHG PHARMACEUTICAL JOINT-STOCK COMPANY

DHG PHARMACEUTICAL JOINT-STOCK COMPANY

Company Profile Report

Company Standard Report

Comprehensive Report

GET IN TOUCH FOR EXCLUSIVE DEALS!

We've just released an update!

Don’t miss any of our insights

DHG PHARMACEUTICAL JOINT-STOCK COMPANY

DHG PHARMACEUTICAL JOINT-STOCK COMPANY

DHG PHARMACEUTICAL JOINT-STOCK COMPANY

Company Profile Report

Company Standard Report

Comprehensive Report

GET IN TOUCH FOR EXCLUSIVE DEALS!

Access Required

Notification